PMC:7405836 / 84823-85039
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T793 | 82-90 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T794 | 82-86 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T795 | 94-102 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T796 | 162-170 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T797 | 162-166 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T798 | 201-215 | Disease | denotes | viral diseases | http://purl.obolibrary.org/obo/MONDO_0005108 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T595 | 0-216 | Sentence | denotes | The majority of the treatment options and strategies that are being evaluated for SARS-CoV-2 (COVID-19) have been taken from our previous experiences in treating SARS-CoV, MERS-CoV, and other emerging viral diseases. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2386 | 82-92 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 2387 | 162-170 | Species | denotes | SARS-CoV | Tax:694009 |
| 2388 | 172-180 | Species | denotes | MERS-CoV | Tax:1335626 |
| 2400 | 94-102 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 2401 | 201-215 | Disease | denotes | viral diseases | MESH:D001102 |